Reporte zur Charge 6N6808

Symptomtext

Difficulty swallowing; Headache; Stiffness in limb; Pain; Chills; Blister on lip; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: 6N6808), via an unspecified route of administration in the left arm on 21Mar2021 at 14:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and hypertension. The patient previously received sulphur (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced allergy. Concomitant medications included valsartan (MANUFACTURER UNKNOWN), atenolol (MANUFACTURER UNKNOWN), salbutamol sulfate (VENTOLIN) and fluticasone propionate, salmeterol xinafoate (SERETIDE); all for an unknown indication from an unknown date. Prior to vaccination, patient was not diagnosed with COVID-19. since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Mar2021 at 21:00, the patient experienced difficulty swallowing within seconds of the vaccine, headache and stiffness in limbs and pain, blister on lip after chills. It was unknown if the patient had received any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events difficulty swallowing, headache, stiffness in limbs, pain, chills and lip blisters was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.